Enliven Therapeutics, Inc.(ELVN:US)
Market Cap$2.272B
Key Metrics
Price$37.32
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$98.78M
EBITDA (TTM)-$115.59M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$132.18M
Total Assets$464.85M
Net Assets$453.37M
Total Debt$302K
Key Metrics
Price$37.32
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$98.78M
EBITDA (TTM)-$115.59M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$132.18M
Total Assets$464.85M
Net Assets$453.37M
Total Debt$302K
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $27.82M | $34.29M | $25.1M | $28.58M | $31.69M | $26.9M | $27.07M | $24.6M | $25.99M | $22.73M | $24.25M | $20.13M | $16.42M | $10.16M | $10.93M | $9.02M | $8.68M | $8.4M | |
| Research and Development | $20.69M | $21.25M | $18.23M | $21.49M | $24.9M | $20.72M | $21.26M | $18.83M | $19.97M | $17.91M | $19.61M | $15.18M | $11.88M | $8.2M | $7.83M | $7.94M | $7.06M | $6.86M |
| Selling, General, and Administrative | $7.14M | $13.04M | $6.87M | $7.09M | $6.8M | $6.17M | $5.81M | $5.78M | $6.02M | $4.82M | $4.64M | $4.95M | $4.54M | $1.97M | $3.11M | $1.08M | $1.62M | $1.53M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$27.82M | -$34.29M | -$25.1M | -$28.58M | -$31.69M | -$26.9M | -$27.07M | -$24.6M | -$25.99M | -$22.73M | -$24.25M | -$20.13M | -$16.42M | -$10.16M | -$10.93M | -$9.02M | -$8.68M | -$8.4M |
| $4.2M | $4.62M | $4.95M | $3.25M | $3.15M | $3.72M | $3.91M | $4.89M | $3.25M | $3.36M | $3.48M | $3.41M | $1.69M | $613K | $380K | $127K | $9K | $3K | |
| Non-Operating Interest Income | $4.2M | $4.62M | $4.95M | $3.25M | $3.2M | $3.72M | $3.84M | $4.09M | $3.25M | $3.37M | $3.49M | $3.41M | $1.69M | $613K | $380K | $127K | $9K | $3K |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | - | $0 | - | -$2K | -$47K | $0 | $73K | $799K | -$1K | -$9K | -$13K | - | - | - | - | - | - | - |
Income Before Tax | -$23.63M | -$29.67M | -$20.15M | -$25.34M | -$28.54M | -$23.18M | -$23.16M | -$19.72M | -$22.74M | -$19.37M | -$20.77M | -$16.72M | -$14.72M | -$9.55M | -$10.55M | -$8.89M | -$8.67M | -$8.39M |
Income Tax | - | $0 | $0 | $0 | - | $0 | $0 | $232K | - | - | $0 | $0 | - | - | - | - | - | - |
Net Income | -$23.63M | -$29.67M | -$20.15M | -$25.34M | -$28.54M | -$23.18M | -$23.16M | -$19.95M | -$22.74M | -$19.37M | -$20.77M | -$16.72M | -$14.72M | -$9.55M | -$10.55M | -$8.89M | -$8.67M | -$8.39M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$23.63M | -$29.67M | -$20.15M | -$25.34M | -$28.54M | -$23.18M | -$23.16M | -$19.95M | -$22.74M | -$19.37M | -$20.77M | -$16.72M | -$14.72M | -$9.55M | -$10.55M | -$8.89M | -$8.67M | -$8.39M |
Shares Outstanding (Basic) | 62.8M | 62.21M | 62.09M | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | - | 41.03M | 40.96M | 18.51M | - | 41.1M | 41.1M | 41.1M | - |
Shares Outstanding (Diluted) | 62.8M | 62.21M | 62.09M | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | - | 41.03M | 40.96M | 18.51M | - | 41.1M | 41.1M | 41.1M | - |
EPS (Basic) | -$0.38 | -$0.48 | -$0.32 | -$0.49 | -$0.57 | -$0.46 | -$0.48 | -$0.41 | -$0.54 | - | -$0.51 | -$0.41 | -$0.80 | - | -$0.26 | -$0.22 | -$0.21 | - |
EPS (Diluted) | -$0.38 | -$0.48 | -$0.32 | -$0.49 | -$0.57 | -$0.46 | -$0.48 | -$0.41 | -$0.54 | - | -$0.51 | -$0.41 | -$0.80 | - | -$0.26 | -$0.22 | -$0.21 | - |
EBIT | -$27.82M | -$34.29M | -$25.1M | -$28.58M | -$31.69M | -$26.9M | -$27.07M | -$24.6M | -$25.99M | -$22.73M | -$24.25M | -$20.13M | -$16.42M | -$10.16M | -$10.93M | -$9.02M | -$8.68M | -$8.4M |
EBITDA | -$27.81M | -$34.24M | -$25.03M | -$28.5M | -$31.62M | -$26.82M | -$27.06M | -$25.33M | -$25.91M | -$22.65M | -$24.17M | -$20.06M | -$16.35M | -$10.1M | -$10.87M | -$8.96M | -$8.64M | -$8.36M |